| D008297 |
Male |
|
Males |
|
| D004195 |
Disease Models, Animal |
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. |
Animal Disease Model,Animal Disease Models,Disease Model, Animal |
|
| D000081223 |
Polycyclic Sesquiterpenes |
Sesquiterpenes that contain two or more ring structures |
Caryophyllane,Caryophyllane Derivative,Caryophyllane Derivatives,Caryophyllanes,Eremophilane,Eremophilane Derivative,Eremophilane Derivatives,Eremophilanes,Polycyclic Sesquiterpene,Valerane,Valerane Derivative,Valerane Derivatives,Valeranes,Derivative, Caryophyllane,Derivative, Eremophilane,Derivative, Valerane,Derivatives, Caryophyllane,Derivatives, Eremophilane,Derivatives, Valerane,Sesquiterpene, Polycyclic,Sesquiterpenes, Polycyclic |
|
| D000280 |
Administration, Inhalation |
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. |
Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D012717 |
Sesquiterpenes |
Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24. |
Farnesanes,Farnesene,Farnesenes,Sesquiterpene,Sesquiterpene Derivatives,Sesquiterpenoid,Sesquiterpenoids,Derivatives, Sesquiterpene |
|
| D012893 |
Sleep Wake Disorders |
Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle. |
Sleep Disorders,Long Sleeper Syndrome,Short Sleep Phenotype,Short Sleeper Syndrome,Sleep-Related Neurogenic Tachypnea,Subwakefullness Syndrome,Disorder, Sleep,Disorder, Sleep Wake,Disorders, Sleep,Disorders, Sleep Wake,Long Sleeper Syndromes,Neurogenic Tachypnea, Sleep-Related,Neurogenic Tachypneas, Sleep-Related,Phenotype, Short Sleep,Phenotypes, Short Sleep,Short Sleep Phenotypes,Short Sleeper Syndromes,Sleep Disorder,Sleep Phenotypes, Short,Sleep Related Neurogenic Tachypnea,Sleep Wake Disorder,Sleep-Related Neurogenic Tachypneas,Sleeper Syndrome, Long,Sleeper Syndrome, Short,Sleeper Syndromes, Long,Sleeper Syndromes, Short,Subwakefullness Syndromes,Syndrome, Long Sleeper,Syndrome, Short Sleeper,Syndrome, Subwakefullness,Syndromes, Long Sleeper,Syndromes, Short Sleeper,Syndromes, Subwakefullness,Tachypnea, Sleep-Related Neurogenic,Tachypneas, Sleep-Related Neurogenic,Wake Disorder, Sleep,Wake Disorders, Sleep |
|
| D012894 |
Sleep Stages |
Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; they formerly included Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. In 2007, sleep stages were redefined by The American Academy of Sleep Medicine (AASM) as: N1-N2 (sleep onset - light sleep), N3 (SLOW-WAVE SLEEP), and REM SLEEP. |
N1-Sleep,N2-Sleep,NREM Stage 1,NREM Stage 2,N1 Sleep,N2 Sleep,Sleep Stage,Stage, Sleep,Stages, Sleep |
|
| D012903 |
Smell |
The ability to detect scents or odors, such as the function of OLFACTORY RECEPTOR NEURONS. |
Olfaction,Sense of Smell,Smell Sense |
|
| D017208 |
Rats, Wistar |
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. |
Wistar Rat,Rat, Wistar,Wistar Rats |
|
-transparent.png){kind=logo}
